Product NDC: | 55289-800 |
Proprietary Name: | Lipitor |
Non Proprietary Name: | atorvastatin calcium trihydrate |
Active Ingredient(s): | 20 mg/1 & nbsp; atorvastatin calcium trihydrate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55289-800 |
Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020702 |
Marketing Category: | NDA |
Start Marketing Date: | 19961217 |
Package NDC: | 55289-800-30 |
Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-800-30) |
NDC Code | 55289-800-30 |
Proprietary Name | Lipitor |
Package Description | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-800-30) |
Product NDC | 55289-800 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | atorvastatin calcium trihydrate |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19961217 |
Marketing Category Name | NDA |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | ATORVASTATIN CALCIUM TRIHYDRATE |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA] |